Continuous positive airways pressure for obstructive sleep apnoea in adults (Review)

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2006, Pages

  Giles, Tammie L ^a   Lasserson, T J ^a   Smith, B J ^a   White, J ^a   Wright, J ^a   Cates, C J ^a  

^a NONE

Author keywords

Adult; Humans; Outcome assessment (HealthCare); Positive pressure respiration *methods ; Randomized controlled trials; Sleep apnea, obstructive *therapy

Indexed keywords

AUTHOR; COCHRANE LIBRARY; COGNITION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA EXTRACTION; DIASTOLIC BLOOD PRESSURE; EPWORTH SLEEPINESS SCALE; FACE MALFORMATION; FACE PRESSURE; HUMAN; HYPOTENSION; INFORMATION; MEDICAL EXPERT; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; OXYGEN SATURATION; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; REGISTER; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP APNEA SYNDROME; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYMPTOM; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; UPPER AIRWAY DRYNESS; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; META ANALYSIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); POSITIVE-PRESSURE RESPIRATION; RANDOMIZED CONTROLLED TRIALS; SLEEP APNEA, OBSTRUCTIVE;

EID: 37649026587     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001106.pub3     Document Type: Review

References (132)

1. Alonso-Fernandez A, Arias MA, Garcia-Rio F, Ramirez M, Fernandez-Lahera J. Impaired left ventricular performance during exercise in patients with obstructive sleep apnea-hypopnea syndrome improves with continuous positive airway pressure. American Thoracic Society 2005 International Conference; May 20-25; San Diego, California. 2005:P523.
2. Arias MA, Alonso-Fernandez A, Garcia-Rio F, Mediano O, Rojo B. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure. American Thoracic Society 2005 International Conference; May 20-25; San Diego, California. 2005:P525.
3. Arias MA, Alonso-Fernandez A, Garcia-Rio F, Santiago A, Lores V. Obstructive sleep apnea is independently associated with daytime pulmonary arterial hypertension that improves with continuous positive airway pressure treatment. American Thoracic Society 2005 International Conference; May 20-25; San Diego, California. 2005: P525.
4. Ballester E, Badia JR, Hernandez L, Carrasco E, de Pablo J, Fornas C, et al. Evidence of the effectiveness of continuous positive airway pressure in the traetment of sleep apnoea/hypopnoea syndrome. American Journal of Respiratory & Critical Care Medicine 1999;159:495-501.
5. Barbè MD, Mayoralas LR, Duran J, Masa JF, Maimo, Montserrat JM, et al. Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea But No Daytime Sleepiness. Annals of Internal Medicine 2001;134:1015-23.
6. Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A, et al. A randomised controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. American Journal of Respiratory & Critical Care Medicine 2002;165:773-80.
7. Barnes M, McEvoy D, Banks S, Tarquinio N, Murray C, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 2004;170:656-64.
8. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Peter JH. Effect of therapeutic and subtherapeutic nasal continuous positive airway pressure (nCPAP) treatment on blood pressure in obstructive sleep apnea (OSA). Sleep Medicine 2003;4(Suppl 1):S3.
9. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Peter JH. Prospective randomized study on the effect of therapeutic and subtherapeutic nasal continuous positive airway pressure (NCPAP) treatment on blood pressure in obstructive sleep apnea (OSA). American Journal of Respiratory and Critical Care Medicine 2001;163(Suppl 5):A838.
10. * Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
11. Jerrentrup A, Becker HF, Nagel R, Ploch T, Stammnitz A, Peter JH. Effect of optimal nasal continuous positive airway pressure (NCPAP) versus low-level NCPAP treatment on ESS and daytime tests in OSA. American Journal of Respiratory and Critical Care Medicine 2000;161(Suppl 3):A355.
12. Chakravorty I, Cayton RM, Szczepura A. Cost effectiveness analysis of nasal CPAP and lifestyle intervention in obstructive sleep apnoea. Thorax 2001;56(Suppl 3):iii27.
13. * Chakravorty I, Cayton RM, Szczepura A. Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome. European Respiratory Journal 2002;20(5):1233-8.
14. Chakravorty I, Raymondd B, Cayton RM, Szczepura A. The health impact of nasal continuous positive airway pressure in sleep apnoea. American Journal of Respiratory & Critcal Care Medicine 2000;161(3):A714.
15. Coughlin SR, Mugarza JA, Mawdsley L, Wilding JPH, Calverley PMA. Continuous positive airways pressure treatment redcues the cardiovascular risk factors associated with obstructive sleep apnoea. American Thoracic Society 100th International Conference, May 21-26, 2004, Orlando. 2004:C99 Poster: 111.
16. Cross MD, Al-Abri M, Newby DE, Riha R, Vennelle M, Douglas NJ. RCT evidence that CPAP improves endothelial function in obstructive sleep apnea hypopnea syndrome (OSAHS) [Abstract]. American Thoracic Society 2005 International Conference; May 20-25; San Diego, California. 2005:C65 Poster K5.
17. Egea C, Pinto J, Ayuela J, Ballester E, Zamarron C, Sojo A, et al. Eficacy of the treatment with CPAP in patients with chronic heart faliure and sleep apnoea. European Respiratory Journal 2004;24(Suppl 48):564s.
18. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airways pressure treatment on daytime function in sleep apnea/hypopnea syndrome. Lancet 1994;343:572-5.
19. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airways pressure therapy for the sleep apnea/hypopnea syndrome: effects in "quot;non- dippers"quot;. Sleep 1996;19:378-81.
20. Engelman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytme function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997;52:114-9.
21. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime fuction after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
22. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnoea/hypopnoea syndrome. American Journal of Respiratory & Critical Care Medicine 1999;159:461-7.
23. Engleman HM, McDonald JP, Graham D, Lello GE, Kingshott RN, Coleman EL, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine 2002;166:855-9.
24. Faccenda 2001 {published data only} Faccenda JF, Boon NA, Mackay TW, Douglas NJ. CPAP effects on blood pressure in the sleep apnea/hypopnea syndrome (SAHS) during a randomized controlled trial. American Journal of Respiratory and Critical Care Medicine 2000;161(Suppl 3):A213.
25. Faccenda JF, Boon NA, Mackay TW, Douglas NJ. Quality of life on and off CPAP in patients with sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine 2000;161(3):A714.
26. * Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomised placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. American Journal of Respiratory & Critical Care Medicine 2001;163:344-8.
27. Ferguson 1996 {published data only} Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance versus nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996;109:1269-75.
28. Ferguson KA, Ono T, Lowe AA, Al-Majed S, Love LL, Fleetham JA. A short term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997;52:362-8.
29. Fleetham JA, Lowe A, Vazquez JC, Ferguson K, Flemons W, Remmers J. A long term randomised parallel multicentre study of an oral appliance versus nCPAP in the treatment of obstructive sleep apnea. American Journal of Respiratory Critical Care Medicine 1998:B33 Poster 613.
30. Fleetham JA, Lowe A, Vazquez JC, Ferguson K, Flemons W, Remmers J. A long term randomised parallel multicentre study of an oral appliance vs nCPAP in the treatment of obstructive sleep apnea. American Journal of Respiratory & Critical Care Medicine 1998:D71.
31. Flemons W, Lowe A, Cazquez JC, Ferguson K, Remmers J, Fleetham J. Quality of life in patients with obstructive sleep apnea treated either with an oral appliance or CPAP. American Journal of Respiratory and Critical Care Medicine 1998;157(3 Suppl):A36.
32. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous postive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine 2001;163:911-7.
33. Choi S, Bennett LS, Mullins R, Davies RJO, Stradling JR. Which derivative from overnight oximetry best predicts symptomatic response to nasal continuous positive airway pressure in patients with obstructive sleep apnoea?. Respiratory Medicine 2000;94(9):895-9.
34. Choi S, Mullins R, Crosby JH, Davies RJO, Stradling JR. Is (re)titration of nasal continuous positive airway pressure for obstructive sleep apnoea necessary?. Sleep Medicine 2001;2(5):431-5.
35. Hack M, Davies RJ, Mullins R, Choi SJ, Ramdassingh-Dow S, Jenkinson C, et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000;55(3):224-31.
36. Hack MA, Davies RJ, Stradling JR. Randomised, shamplacebo, parallel study of the effect of nasal continuous positive airway pressure (NCPAP) on steering performance in patients with obstructive sleep apnoea (OSA) - interim analysis. Thorax 1998;53(Suppl 4):A44.
37. Jenkinson C, Davies RJ, Mullins R, Stradling J. Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea. QJM 2001;94(2):95-9.
38. * Jenkinson C, Davies RJO, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airways pressure for obstructive sleep apnoea; a randomised prospective parallel trial. Lancet 1999;353:2100-5.
39. Meston N, Davies RJ, Mullins R, Jenkinson C, Wass JA, Stradling JR. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. Journal of Internal Medicine 2003;254(5):447-54.
40. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004;59(9):777-82.
41. Stradling JR, Davies RJO. Is more NCPAP better?. Sleep 2000;23(Suppl 4):S150-3.
42. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs contiuous positive airway pressure in patients with positional obstructive sleep apnoea. Chest 1999;115:771-81.
43. * Kaneko Y, Floras J, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. New England Journal of Medicine 2003;348(13):1233-41.
44. Kaneko Y, Plante J, Kubo T, Tkacova R, Ando S, Florus JS, et al. Effects of CPAP on cardiac function in heart failure patients with obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 2002;165(Suppl 8):A247.
45. Lam B, Sam K, Cheung MT, Mok W, Lam J, Tsang KWT, et al. A randomized controlled study for the treatment ofmild/moderate onstructive sleep apnea (OSA) [Abstract]. Sleep Medicine 2003;4(Suppl 1):S26.
46. Lim LL. Effect of CPAP therapy on pain, disability and quality of life in chronic daily headache and sleep apnea: a randomized controlled trial. Neurology 2005;64(6):A24.
47. Lojander J, Maasilta P, Partinen M, Brander PE, Salmi T, Lehtonen H. Nasal CPAP, Surgery and conservativemanagement for treatment of obstructive sleep apnoea syndrome. Chest 1996;110:114-9.
48. Mansfield D, Gollogly NC, Bergin P, Richardson M, Kaye DM, Naughton MT. Congestive heart failure and obstructive sleep apnea trial of continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine 2002;165(Suppl 8):B21.
49. * Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. American Journal of Respiratory & Critical Care Medicine 2004;169(3):361-6.
50. Marshall NS, Neill AM, Campbell AJ, Sheppard DS. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Thorax 2005;60(5):427-32.
51. * McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. American Journal of Respiratory & Critical Care Medicine 2001;164(8):1459-63.
52. McArdle N, Douglas NJ. Randomized crossover study of sleep quality of bed-partners of patients with sleep apnea/hypopnea. American Journal of Respiratory and Critical Care Medicine 2000;161(3):A714.
53. Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barb'e F, et al. Effectiveness of Continuous Positive Airway Pressure in Mild Sleep Apnea-Hypopnoea Syndrome. American Journal of Respiratory & Critical Care Medicine 2001;164:939-43.
54. Hernandez L, Ballester E, Vilagut G, Ferrer M, Carrasco E, DePablo J, et al. A randomized placebo controlled study on the effectiveness of CPAP treatment. American Journal of Respiratory and Critical Care Medicine 2000;161(Suppl 3):A358.
55. Hernandez L, Farre R, Ballester E, Navajas D, Montserrat JM. Compliance of sham-cpap compared with optimal cpap in sleep apnea syndrome. European Respiratory Society; 1999 Oct 9-13; Madrid, Spain. 1999:P2705.
56. * Montserrat JM, Montserrat F, Hernandez L, Farre R, Vilagut G, Navajas D, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome. American Journal of Respiratory & Critical Care Medicine 2001;164:608-13.
57. Olson LG, Ambrogetti A, Trevillian Z. A randomised crossover comparison of nasal CPAP and amandibular advancement splint in mild obstructive sleep apnea. 2002.
58. * Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Abstract ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;59(9302):204-10.
59. Pepperell JCT, Mullins B, Dow SR, Crosthwaite N, Stradling JR, Davies RJO. Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP). Thorax 2000;55(Suppl 3):A24.
60. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004;59(9):777-82.
61. Randerath W, Heise M, Galetke W, Hinz R, Rühle K-H. Prospective randomised comparison of a three dimensional adjustabale protrusion device with CPAP inmild obstrictive sleep apnoea [Prospektiver randomiserter Vergleich einer dreidimnsional-variablen Protrusionsschiene mit CPAP beim leichtgradigen obstruktiven Schlafapnoe-Synfrom]. Pneumologie 2001;55:73s [poster: P101].
62. * Randerath WJ, Heise M, Hinz R, Ruehle KH. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002;122(2):569-75.
63. L'Estrange PR, Smith C, Grant HR, Makker HK, Spiro SG. Pilot randomised trial of nasal continuous positive airway pressure (cpap) ventilation versus a mandibular advancement splint (mas) in severe obstructive sleep apnoea (osa): early difficulties. European Respiratory Society; 1999 Oct 9-13; Madrid, Spain. 1999:P2701.
64. Tan YK, Estrange PL, Grant HR, Smith C, Simonds AK, Spiro SG. A randomised crossover study of continuous positive airway pressure (CPAP) vsmandibular advancement splint (MAS) in mild andmoderate obstructive sleep apnoeas (OSA). European Respiratory Journal 1998;12(Suppl 28):5S.
65. Tan YK, L'Estrange PR, Grant HR, Smith C, Simonds AK, Spiro SG. A randomised crossover study of continuous positive airway pressure (CPAP) vs mandibular advancement splint (MAS) in mild and moderate obstructive sleep apnoea (OSA). Thorax 1998;53(Suppl 4):A4.
66. Tan YK, L'Estrange PR, Grant HR, Smith C, Simonds AK, Spiro SG. Subjective assessment of continuous positive airway pressure (CPAP) and a mandibular advancement splint (MAS) in a randomised crossover study of patients with mild or moderate obstructive sleep apnoea (OSA). Thorax 1998;53(Suppl 4):A4.
67. * Tan YK, L'Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, et al. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomised cross-over trial. European Journal of Orthodontics 2002;24(3):239-49.
68. Bedard MA, Montplaisir J, Malo J, Richer F, Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). Journal of Clinical and Experimental Neuropsychology 1993;15:330-41.
69. Clark G T, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 1996;109:1477-83.
70. Davies RJ, Harrington KJ, Ormerod O, Stradling JR. Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. American Review of Respiratory Disease 1993;147:630-34.
71. Davies RJ, Crosby J, Prothero A, Stradling JR. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment. Clinical Science 1994;86:417-24.
72. Davies RJ, Turner R, Crosby J, Stradling JR. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring their comparison withmatched controls and response to treatment. Journal of Sleep Research 1994;3:180-5.
73. Derderian SS, Bridenbaugh RH, Rajagopal KR. Neuropsychologic symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure. Chest 1988;94:1023-7.
74. Dimsdale, J, Loredo J, Profant J. Effect of continuous positive airway pressure on blood pressure; a placebo trial. Hypertension 2000;35:144-7.
75. Engleman HM, Cheshire KE, Deary IJ, Douglas NJ. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax 1993;48:911-4.
76. Findley LJ, Fabrizio MJ, Knight H, Norcross BB, LaForte A J, Suratt PM. Driving simulator performance in patients with sleep apnea. American Review of Respiratory Disease 1989;140:529-30.
77. Guilleminault C, Stoohs R, Duncan S. Snoring: daytime sleepiness in regular heavy snorers. Chest 1992;99:40-8.
78. Huang R, Huang XZ, Xiao Y. Evaluation of an auto-CPAP device for treatment of obstructive sleep apnea. Beijing Medical Journal 2001;2(6):350-352.
79. Jennum P, Wildschiotz G, Christensen NJ, Schwartz T. Blood pressure, catecholamines and pancreatic polypeptide in OSA with and without CPAP treatment. American Journal of Hypertension 1989;2:847-52.
80. Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A congnitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomised study. Sleep Medicine 2004;5:125-31.
81. Kribbs NB, Pack AI, Kline LR, Getsy JE, Schuett JS, Henry JN, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnoea. American Review of Respiratory Disease 1993;147:1162-8.
82. Krieger J, Grucker D, Sforza E, Chambron J, Kurtz D. Left ventricular ejection fraction in obstructive sleep apnea, effects of long termtreatment with nasal continuous positive airways pressure. Chest 1991;100:917- 21.
83. Lamphere J, Roehrs T, Wittig R, Zorick F, Conway W A, Roth T. Recovery of alertness after CPAP in apnea. Chest 1989;96:1364-7.
84. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of contiuous positive airways pressure on sleep quality in obstructive sleep apnea. Chest 1999;116:1545-9.
85. Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, von Wichert P. Blood pressure and sleep apnea: results of long term continuous positive airway pressure therapy. Cardiology 1991;79:84-92.
86. Naughton MT, Benard DC, Rutherford R, Bradley TD. Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. American Journal of Respiratory & Critical Care Medicine 1994;150(61):1598-604.
87. Profant J, Ancoli-Israel S, Dimsdale JE. A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of life. Heart & Lung 2003;32:52-8.
88. Rajagopal KR, Bennett LL, Dillard TA, Tellis CJ, Tenholder MF. Overnight CPAP improves hypersomnolence in sleep apnea. Chest 1986;90:172-6.
89. Rauscher H, Formanek D, Popp W, Zwick H. Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea. Thorax 1993;48:529-33.
90. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. American Journal of Respiratory & Critical Care Medicine 1998;157(3):858-65.
91. Sangal RB, Thomas L, Mitler MM. Disorders of excessive sleepiness. Treatment improves ability to stay awake but does not reduce sleepiness. Chest 1992;102:699-703.
92. Sforza A, Krieger J, Weitzemblum E, Apprill M, Lampert E, Ratamaharo J. Long term effects of treatment with nasal continuous positive airways pressure on daytime lung function and pulmonary haemodynamics in patients with obstructive sleep apnea syndrome. American Review of Respiratory Disease 1990;141:866-70.
93. Sforza E, Krieger J. Daytime sleepiness after longterm continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome. Journal of Neurological Science 1992;110:21-6.
94. Sforza E, Capecchi V, Lugaresi E. Haemodynamic effects of short-term nasal continuous positive airway pressure therapy in sleep apnoea syndrome: monitoring by a finger arterial pressure device. European Respiratory Journal 1992;5(7):858-63.
95. Stoohs RA, Facchini FS, Philip P, Valencia-Flores M, Guilleminault C. Selected cardiovascular risk factors in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure (n-CPAP). Sleep 1993;16:S141-2.
96. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993;16:545-9.
97. Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FL, Fletcher PJ, et al. Effect of nasal continuous positive airway pressure during sleep on 24- hour blood pressure in obstructive sleep apnea. Sleep 1993;16:539-44.
98. Steward DL, Weaver EM, Woodson BT. A comparison of radiofrequency treatment schemes for obstructive sleep apnea syndrome. Otolaryngology - Head & Neck Surgery 2004;130(5):579-85.
99. Weaver EM, Woodson BT, Steward DL. Polysomnography indexes are discordant with quality of life, symptoms, and reaction times in sleep apnea patients. Otolaryngology -Head & Neck Surgery 2005;132(2):255-62.
100. Woodson BT, Steward DL, Weaver EM. Outcomes of non-attended home autosetting CPAP titration. Sleep Medicine 2003;4(Suppl 1):S53.
101. * Woodson BT, Steward DL, Weaver EM, Javaheri S. A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngology - Head & Neck Surgery 2003;128(6):848-61.
102. Yamashiro Y, Kryger MH. CPAP titration for sleep apnea using a split-night protocol. Chest 1995;107(1):62-6.
103. Yu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. Journal of Psychiatric Research 1999;33:427-432.
104. Zeigler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnoea. Chest 2001;120:887-93.
105. Zorick FJ, Roehrs T, Conway W, Potts G, Roth T. Response to CPAP and UPPP in apnea. Henry Ford Hospital Medical Journal 1990;38(4):223-6.
106. The American Academy of Sleep Medicine Task Force. Sleep Related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22(5):667- 89.
107. Aubert-Tulkens G, Culee C, Rodenstein DO. Cure of sleep apnea syndrome after long-term nasal continuous positive airway pressure therapy and weight loss. Sleep 1989;12(3):216-22.
108. Brennan VK, Osman LM, Graham H, Critchlow A, Everard ML. True device compliance: the need to consider both competence and contrivance. Respiratory Medicine 2005;99(1):97-102.
109. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. European Respiratory Journal 1995;8:1161-78.
110. Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994;344:653-5.
111. Haniffa M, Lasserson TJ, Smith I. Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea (Cochrane review). In: The Cochrane Database of Systematic Reviews, 4, 2004 Art. No.: CD003531.pub2. DOI: 10.1002/14651858.CD003531.pub2..
112. Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
113. Kingshott RN, Vennelle M, Hoy CJ, Engleman HM, Deary IJ, Douglas NJ. Predictors of improvements in daytime function outcomes with CPAP therapy. American Journal of Respiratory Critical Care Medicine 2000;161(3):866-71.
114. Lavie P. Pro: Sleep apnea causes cardiovascular disease. Amercian Journal of Respiratory and Critical Care Medicine 2004;169(2):148-9.
115. Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea (Cochrane review). In: The Cochrane Database of Systematic reviews, 4, 2004 Art. No.: CD004435.pub2. DOI: 10.1002/14651858.CD004435.pub2..
116. Mayer P, Pepin JL, Bettega G, Veale D, Ferretti G, Deschaux C, Levy P. Relationship between body mass index, age and upper airwaymeasurements in snorers and sleep apnoea patients. European Respiratory Journal 1996;9:1801-9.
117. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. American Journal of Respiratory & Critcal Care Medicine 2001; 164(10):1910-3.
118. Patel SR, White D, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleepa apnoea: results of ameta-analysis. Archives of Internal Medicine 2003;163(5):565-71.
119. Pepperell JC, Davies RJ, Stradling JR. Systemic hypertension and obstructive sleep apnoea. Sleep Medicine Reviews 2002;6(3):157-73.
120. Phillipson EA. Sleep apnoea - a major public health problem. New England Journal of Medicine 1993;328:1271-3.
121. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004;59(9):777-82.
122. Shneerson J, Wright J. [Lifestyle modification for obstructive sleep apnoea]. In: The Cochrane Database of Systematic Reviews, 1, 2001 Art. No.: CD002875. DOI: 10.1002/14651858.CD002875..
123. Scottish Intercollegiate Guideline Network. Management of obstructive sleep apnoea/hypopnoea syndrome in adults (guideline no. 73). www.sign.ac.uk.
124. Smith I, Lasserson TJ, Wright J. Drug treatments for obstructive sleep apnoea (Cochrane review). In: The Cochrane Database of Systematic Reviews, 4, 2001 Art. No.: CD003002. DOI: 10.1002/14651858.CD003002..
125. Stepnowsky Jr CJ, Moore P. Nasal CPAP treatment for obstructive sleep apnea. Developing a new perspective on dosing strategies and compliance. Journal of Psychosomatic Research 2003;54:599-605.
126. Sradling JR, Davies RJO. Sleep. 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax 2004;59(1):73-8.
127. Stradling J. Con: Sleep apnea does not cause cardiovascular disease. American Journal of Respiratory and Crtitical Care Medicine 2004;169(2):148-9.
128. Sundaram S, Bridgman SA, Lim J, Lasserson TJ. Surgery for obstructive sleep apnoea. In: Cochrane Database of Systematic Reviews, 4, 2005.
129. Wild MR, Engleman HM, Douglas NJ, Espie CA. Can psychological factors help us to determine adherence to CPAP? A prospective study. European Respiratory Journal 2004;24(3):461-5.
130. Wright J, Dye R, Watt I, Melville A, Sheldon T. The health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the evidence. BMJ 1997;314:851- 60.
131. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurance of sleep-disorded breathing among middle-aged adults. New England Journal of Medicine 1993;328:1230-5.
132. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. American Journal of Respiratory and Critical Care Medicine 2002;165(9):1217-39.